Re-irradiation plus pembrolizumab: Phase II study for recurrent glioblastoma patients

Iwamoto, F. M., Tanguturi, S. K., Nayak, L., Wang, T. J., Desai, A., Lustig, R. A., Bagley, S., Wong, E. T., Hertan, L. M., McCluskey, C., Hayden, J., Muzikansky, A., Nakhawa, S., Japo, J., Bossi, C. C., Meylan, M., Tian, Y., Barlow, G. L., Speliakos, P., … Reardon, D. A. (2024). Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma. Clinical Cancer Research, OF1–OF12. https://doi.org/10.1158/1078-0432.ccr-24-1629
Authors:
Fabio M Iwamoto
Shyam K Tanguturi
Lakshmi Nayak
Tony J Wang
Arati Desai
Robert A Lustig
Stephen Bagley
Eric T Wong
Lauren M Hertan
Christine McCluskey
Julia Hayden
Alona Muzikansky
Shreya Nakhawa
Julia Japo
Connor C Bossi
Maxime Meylan
Ye Tian
Graham L Barlow
Paul Speliakos
Georges Ayoub
David M Meredith
Keith L Ligon
Daphne Haas-Kogan
Kun Huang
Kai W Wucherpfennig
Patrick Y Wen
David A Reardon
Affiliated Authors:
Tony J Wang
Publication Type:
Article
Unique ID:
10.1158/1078-0432.ccr-24-1629
PMID:
Publication Date:
Data Source:
PubMed

Record Created: